Get reliable data
Signant SmartSignals Oncology Study Solutions
Alleviate site & sponsor burden
Support patient needs
Designed with oncology challenges in mind, our Signant SmartSignals solutions can be implemented individually or together for a fully digital experience.
PRE-CONFIGURED eCOA
PATIENT CONCIERGE
SENSORS & WEARABLES
We created a pre-configured eCOA solution that incorporates pre-validated library instruments and oncology-specific features. Eliminating the issues common in paper administration, our eCOA collects accurate data in a fraction of the time and at a reduced cost.
Conveniently located on the same app as our eCOA solution, this engagement tool promotes site-patient communication throughout the study, not just during acute treatment and post-treatment follow up. Built-in reminders, visit schedules, and disease-specific information will drive completion adherence.
When integrated with our eCOA solution, these wearable devices stream real-time, objective data on sleep and activity patterns. Your study team will gain a better understanding of the post-treatment recovery associated with each treatment cycle.
Randomization and Trial Supply Management (RTSM) uses proprietary algorithms to optimize expensive oncology supplies even in the most complex study design. The solution can help you maintain the study’s blind and protect patients’ privacy.
Capture a fully informed consent at home or on site by educating patients through multimedia and allowing them to flag sections they need clarified. The solution ensures that patients sign the correct forms after protocol amendments to limit the risk of inspection findings.
Improve Your Oncology Studies With Signant
Providing High-Quality Data for Informed Decision-Making
Signant SmartSignals advanced solutions and Signant's unrivaled experience help study teams overcome challenges common in oncology studies.
With our support, your clinical researchers can develop novel treatments and therapies to help oncology patients everywhere.
